Long-term Follow-up of Patients With Alcoholic Liver Cirrhosis Who Had Administered Cellgram-LC in PMC-P-07 Study

Recruiting now · Not applicable

Conditions studied: Alcoholic Cirrhosis

In brief

This Long-term follow-up is designed to evaluate the safety of patient with Alcoholic Liver Cirrhosis who had administered Cellgram-LC in PMC-P-07 study.

Key facts

Study ID

NCT05093881

Run by

Pharmicell Co., Ltd.

People needed

100

Starts

2021-08-24

Expected to finish

2028-03-31

Last updated by the study team

2024-03-21

Who can join

Age: any. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Those who participated in PMC-P-07 clinical trials and received Cellgram-LC
• Those who voluntarily agreed in writing to participate in this investigation

Where it is running

• Soonchunhyang University Hospital — Bucheon-si, South Korea (enrolling)
• Soonchunhyang University Hospital — Cheonan, South Korea (enrolling)
• Gangwon National University Hospital — Chuncheon, South Korea (enrolling)
• Hallym Univ. Medical Center — Chuncheon, South Korea (enrolling)
• Gangneung Asan Hospital — Gangneung-si, South Korea (enrolling)
• Eunpyeong St. Mary's Hospital — Seoul, South Korea (enrolling)
• Korea University Anam Hospital — Seoul, South Korea (enrolling)
• Seoul National University Hospital — Seoul, South Korea (enrolling)
• Soonchunhyang University Hospital — Seoul, South Korea (enrolling)
• Wonju Severance Christian Hospital — Wŏnju, South Korea (enrolling)
• Yongin Severance Hospital — Yongin, South Korea (enrolling)

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.